Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...

REITs are positioned for accelerating earnings growth in 2026-2027, with management teams expressing increased optimism ...

The S&P and Nasdaq notched fresh record highs Wednesday, because apparently the best time to chase stocks is when jobs ...

The YieldMax HOOD Option Income Strategy ETF offers a covered call strategy on Robinhood. Click here to read why I rate HOOY ...

Sony's stock may still be undervalued despite recent gains. Click to read more about SONY's entertainment strategy and risks ...

My 4-Factor Dividend Growth Portfolio offers automated stock selection, strong returns, and 9.55% dividend CAGR. Click to ...

PWB ETF offers exposure to approximately 50 leading large-cap growth stocks amid macro challenges. Read more on risks, the ...

Altria's dominant U.S. market share, strong pricing power, and brand loyalty provide a robust moat despite declining ...

Datadog (DDOG) leaped 9% during post-market trading on Wednesday after it was revealed the company will replace Juniper ...

Fortinet is a top cybersecurity leader with strong growth, profitability, and recurring revenue. Click to find out why FTNT ...

Netflix stock looks overbought after a major rally, facing growth challenges and high valuation risks. Read more on why NFLX ...

Palantir Technologies (NASDAQ:PLTR) creates big data analytics software platforms that assist governments and companies in ...